Parimal Nathwani

About

Parimal Nathwani is the Vice-President of Life Sciences at MaRS Innovation since December 2008. Parimal is a biotechnology executive with over 15 years of experience working in the area of new venture creation, financing, business development, licensing and corporate strategy. Parimal is also the President and Chief Executive Officer at Vasomune Inc. Parimal also is an active participant within the biotechnology community - he is the Executive Chairman of ScaRX Therapeutics and a Board Observer for Encycle Therapeutics and DLVR Therapeutics. Prior to his current roles, Parimal was a healthcare analyst with a boutique investment bank, where he conducted due diligence on publicly-traded biotechnology companies in Canada and the U.S. for an institutional investor client base and advised companies on financing strategies. Parimal has also held the position of technology transfer manager in the life sciences at one of Canada’s leading technology transfer offices and business develop

Investment Focus

Location

Toronto, Canada